Monitoring SARS-CoV-2 variants. 2021. https://www.who.int/en/actions/tracking-SARS-CoV-2-variants/.
Chinn J, Sedighim S, Kirby KA, Hohmann S, Hameed AB, Jolley J, et al. Traits and outcomes of girls with COVID-19 giving start at US Tutorial Facilities in the course of the COVID-19 pandemic. JAMA Netw Open. 2021;4:e2120456–e2120456. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782978.
Google Scholar
Kids and COVID-19: state-level information report. 2021. https://companies.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/.
Beharier O, Mayo RP, Raz T, Sacks KN, Schreiber L, Suissa-Cohen Y, et al. Environment friendly maternal to neonatal switch of antibodies in opposition to SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J Clin Make investments. 2021;131:e150319.
Shook LL, Atyeo CG, Yonker LM, Fasano A, Grey KJ, Alter G, et al. Sturdiness of anti-spike antibodies in infants after maternal COVID-19 vaccination or pure an infection. JAMA. 2022. https://jamanetwork.com/journals/jama/fullarticle/2788986.
Halasa NB, Olson SM, Staat MA, Newhams MM, Worth AM, Increase JA, et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine throughout being pregnant in opposition to COVID-19-associated hospitalization in infants aged. MMWR Morb Mortal Wkly Rep. 2022;71:264–70. https://pubmed.ncbi.nlm.nih.gov/35176002/.
Google Scholar
Nir O, Schwartz A, Toussia-Cohen S, Leibovitch L, Strauss T, Asraf Ok, et al. Maternal-neonatal switch of SARS-CoV-2 immunoglobulin G antibodies amongst parturient girls handled with BNT162b2 messenger RNA vaccine throughout being pregnant. Am J Obstet Gynecol. 2022;4. https://pubmed.ncbi.nlm.nih.gov/34547533/.
Narayanaswamy V, Pentecost BT, Schoen CN, Alfandari D, Schneider SS, Baker R, et al. Neutralizing antibodies and cytokines in breast milk after coronavirus illness 2019 (COVID-19) mRNA vaccination. Obstet Gynecol. 2022;139:181–91. https://journals.lww.com/greenjournal/Fulltext/2022/02000/Neutralizing_Antibodies_and_Cytokines_in_Breast.6.aspx.
Google Scholar
Grey KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Younger N, et al. Coronavirus illness 2019 vaccine response in pregnant and lactating girls: a cohort examine. Am J Obstet Gynecol. 2021;225:303.e1–303.e17. http://www.ajog.org/article/S0002937821001873/fulltext.
Google Scholar
Valcarce V, Stafford LS, Neu J, Cacho N, Parker L, Mueller M, et al. Detection of SARS-CoV-2-specific IgA within the human milk of COVID-19 vaccinated lactating well being care employees. 2021. https://www.liebertpub.com/doi/abs/10.1089/bfm.2021.0122.
Perl SH, Uzan-Yulzari A, Klainer H, Asiskovich L, Teenager M, Rinott E, et al. SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding girls. JAMA. 2021. http://www.ncbi.nlm.nih.gov/pubmed/33843975.
Ramírez DSR, Pérez MML, Pérez MC, Hernández MIS, Pulido SM, Villacampa LP, et al. SARS-CoV-2 antibodies in breast milk after vaccination. Pediatrics. 2021;e2021052286. https://pediatrics.aappublications.org/content material/early/2021/10/07/peds.2021-052286.
Tempo RM, Williams JE, Järvinen KM, Belfort MB, Tempo CDW, Lackey KA, et al. Characterization of sars-cov-2 rna, antibodies, and neutralizing capability in milk produced by girls with covid-19. MBio. 2021;12:1–11. https://mbio.asm.org/content material/12/1/e03192-20.
Google Scholar
Fox A, Marino J, Amanat F, Krammer F, Hahn-Holbrook J, Zolla-Pazner S, et al. Sturdy and particular secretory IgA in opposition to SARS-CoV-2 detected in human milk. iScience. 2020;23. https://pubmed.ncbi.nlm.nih.gov/33134887/.
Peng S, Zhu H, Yang L, Cao L, Huang X, Dynes M, et al. A examine of breastfeeding practices, SARS-CoV-2 and its antibodies within the breast milk of moms confirmed with COVID-19. Lancet Reg Heal West Pac. 2020;4:100045 https://doi.org/10.1016/j.lanwpc.2020.10.
Google Scholar
Baird JK, Jensen SM, Urba WJ, Fox BA, Baird JR. SARS-CoV-2 antibodies detected in mom’s milk post-vaccination. J Hum Lact. 2021;37:492–8.
Atyeo C, Alter G. The multifaceted roles of breast milk antibodies. Cell. 2021;184:1486–99. https://pubmed.ncbi.nlm.nih.gov/33740451/.
Google Scholar
Hassiotou F, Geddes DT, Hartmann PE. Cells in human milk: state of the science. J Hum Lact. 2013;29:171–82. https://pubmed.ncbi.nlm.nih.gov/23515088/.
Google Scholar
Hassiotou F, Geddes DT. Immune cell-mediated safety of the mammary gland and the toddler throughout breastfeeding. Adv Nutr. 2015;6:267–75. https://pubmed.ncbi.nlm.nih.gov/25979492/.
Google Scholar
Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the practical receptor for SARS coronavirus. A primary step in understanding SARS pathogenesis. J Pathol. 2004;203:631.
Google Scholar
Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3.
Guo M, Tao W, Flavell RA, Zhu S. Potential intestinal an infection and faecal–oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021;18:1.
Wang Q, Li Y, Lung DC, Chan PT, Dung CH, Jia W, et al. Aerosol transmission of SARS-CoV-2 because of the chimney impact in two high-rise housing drainage stacks. J Hazard Mater. 2022;421:126799.
Woodford J, Sagara I, Dicko A, Zeguime A, Doucoure M, Kwan J, et al. Extreme acute respiratory syndrome coronavirus 2 seroassay efficiency and optimization in a inhabitants with excessive background reactivity in Mali. J Infect Dis. 2021;224:2001–9. https://tutorial.oup.com/jid/article/224/12/2001/6382154.
Google Scholar
Younger BE, Seppo AE, Diaz N, Rosen-Carole C, Nowak-Wegrzyn A, Cruz Vasquez JM, et al. Affiliation of human milk antibody induction, persistence, and neutralizing capability with SARS-CoV-2 an infection vs mRNA vaccination. JAMA Pediatr. 2022;176:159–68. https://jamanetwork.com/journals/jamapediatrics/fullarticle/2786219.
Google Scholar
Evans JP, Zeng C, Carlin C, Lozanski G, Saif LJ, Oltz EM, et al. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough an infection. Sci Transl Med. 2022. https://pubmed.ncbi.nlm.nih.gov/35166573/.
Gillot C, Favresse J, Maloteau V, Dogné JM, Douxfils J. Dynamics of neutralizing antibody responses following pure SARS-CoV-2 an infection and correlation with industrial serologic checks. A reappraisal and oblique comparability with vaccinated topics. Viruses. 2021;13. https://pubmed.ncbi.nlm.nih.gov/34835135/.
Grey KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Younger N, et al. COVID-19 vaccine response in pregnant and lactating girls: a cohort examine. Am J Obstet Gynecol. 2021;0. https://linkinghub.elsevier.com/retrieve/pii/S0002937821001873.
Hua CZ, Miao ZP, Zheng JS, Huang Q, Solar QF, Lu HP, et al. Epidemiological options and viral shedding in youngsters with SARS-CoV-2 an infection. J Med Virol. 2020;92:2804–12. https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26180.
Google Scholar
Demers-Mathieu V, DaPra C, Mathijssen GB, Medo E. Earlier viral signs and particular person moms influenced the leveled period of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43. J Perinatol. 2021;41:952.
Demers-Mathieu V, Dapra C, Mathijssen G, Sela DA, Järvinen KM, Seppo A, et al. Human milk antibodies in opposition to S1 and S2 subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in moms with a confirmed COVID-19 PCR, viral SYMPTOMS, and unexposed moms. Int J Mol Sci. 2021;22:1–13.
Google Scholar
Perrier C, Sprenger N, Corthésy B. Glycans on secretory part take part in innate safety in opposition to mucosal pathogens*. J Biol Chem. 2006;281:14280–7. http://www.jbc.org/article/S0021925820780737/fulltext.
Google Scholar
Mestecky J, Russell MW. Particular antibody exercise, glycan heterogeneity and polyreactivity contribute to the protecting exercise of S-IgA at mucosal surfaces. Immunol Lett. 2009;124:57.
Moriyama S, Adachi Y, Sato T, Tonouchi Ok, Solar L, Fukushi S, et al. Temporal maturation of neutralizing antibodies in COVID-19 convalescent people improves efficiency and breadth to circulating SARS-CoV-2 variants. Immunity. 2021;54:1841.
Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody ranges are extremely predictive of immune safety from symptomatic SARS-CoV-2 an infection. Nat Med. 2021;27:1205–11.
Google Scholar
